1987
DOI: 10.1016/s0034-5288(18)30655-6
|View full text |Cite
|
Sign up to set email alerts
|

A single vaccine for the control of capripox infection in sheep and goats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
68
0

Year Published

1999
1999
2023
2023

Publication Types

Select...
3
2
2

Relationship

0
7

Authors

Journals

citations
Cited by 99 publications
(69 citation statements)
references
References 10 publications
1
68
0
Order By: Relevance
“…It did not exhibit R 6 and the sheep-like gap, but featured a real SPPV signature for all other amino acid motifs. SPPV15 (strain KS-1) was originally isolated from a sheep and later shown by restriction enzyme digestion analysis to have an LSDV profile (Kitching et al, 1987). This is confirmed in this study, as KS-1 did not possess the SPPV-like gap and had a clear LSDV signature.…”
supporting
confidence: 81%
See 3 more Smart Citations
“…It did not exhibit R 6 and the sheep-like gap, but featured a real SPPV signature for all other amino acid motifs. SPPV15 (strain KS-1) was originally isolated from a sheep and later shown by restriction enzyme digestion analysis to have an LSDV profile (Kitching et al, 1987). This is confirmed in this study, as KS-1 did not possess the SPPV-like gap and had a clear LSDV signature.…”
supporting
confidence: 81%
“…These included 22 strains isolated from sheep, 12 from goats, 13 from cattle and 2 from springbok antelopes (Antidorcas marsupialis) (Supplementary Table S1, available in JGV Online). Eight of the isolates were vaccine strains: a goat pox vaccine from Kazakhstan [GTPV1 in Supplementary Table S1 (Kitching et al, 1987)], a sheep and goat vaccine strain (SPPV14 and GTPV4, respectively) used for routine vaccination in Nigeria (sent by Dr Majiyagbe, National Veterinary Research Institute, Vom, Plateau State, Nigeria), the Onderstepoort LSD Neethling vaccine strains [LSDV1, partial sequence (Fick & Viljoen, 1994) and LSDV3 full genome sequence (Kara et al, 2003)], an LSD vaccine used in Nigeria (LSDV8), the Romanian sheep pox vaccine strain produced by Biopharma, in Morocco (SPPV11), a sheep pox vaccine from Kazakhstan [SPPV3 (Tulman et al, 2002)], the sheep pox vaccine strain Nihkhi from Kazakhstan [SPPV3 (Tulman et al, 2002)] and the Kenya sheep vaccine isolate of LSDV [KS-1, SPPV15 (Kitching et al, 1987)]. They were compared to the corresponding sequences of three SPPV, two GTPV and four LSDV isolates retrieved from GenBank in October 2008.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Neither of the recipient animals developed antibody levels detectable using SNT. It is, however, known that the immunity against LSDV is predominantly cell-mediated, and none of the serological assays that are currently available are sufficiently sensitive to detect antibodies consistently during and after mild infections of LSD (Kitching et al, 1987).…”
Section: Discussionmentioning
confidence: 99%